Monkeypox patients could be infectious for up to 4 weeks: Experts

Health experts have reportedly said that Monkeypox patients could pass on the disease for up to four weeks after symptoms appear.

Monkeypox
Amesh Adalja, an emerging infectious diseases experts at John Hopkins University, made the warning in an interview that monkeypox patients could be infectious for up to four weeks, reports the DailyMail.
IANS New York
2 min read Last Updated : May 21 2022 | 5:43 PM IST

Health experts have reportedly said that Monkeypox patients could pass on the disease for up to four weeks after symptoms appear.

Amesh Adalja, an emerging infectious diseases experts at John Hopkins University, made the warning in an interview that monkeypox patients could be infectious for up to four weeks, reports the DailyMail.

People who catch the virus initially suffer a fever before rashes and skin lesions appear on the face and body. The virus can then be passed on through touching the affected areas or via droplets expelled in coughs and sneezes.

"It can take a few weeks for the skin lesions to disappear. People are contagious until their active skin lesions have dissipated," he said.

Michael Head, a global health expert at Southampton University in England, agreed with his assertion, the report said.

"Based on previous monkeypox outbreaks and guidance from [UK health authorities] and WHO, the infectious period (i.e. when the virus can be transmitted to another person) can be comparable to the time period where the rash and blisters are present," Head said.

"This may be for two weeks, and may be longer," he added.

The month-long infectious period raises the likelihood that the virus could be passed on by infected patients to others.

More than 80 cases of monkeypox have been confirmed in at least 12 countries, the WHO has said.

The WHO mentioned another 50 suspected cases are being investigated, without naming any countries, and warned that more cases are likely to be reported.

Infections have been confirmed in nine European countries, as well as the US, Canada and Australia.

The Food and Drug Administration (FDA) approved a smallpox drug to treat monkeypox patients, while the WHO revealed it will hold daily meetings as the situation unfolds.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :disease

First Published: May 21 2022 | 5:38 PM IST

Next Story